Two Sigma Advisers
MBIO icon

Two Sigma Advisers’s Mustang Bio MBIO Stock Holding History

Two Sigma Advisers’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-72
Closed -$19.9K – 2555
2023
Q1 		$19.9K Sell
72
-4
-5% -$1.64K ﹤0.01% 2517
2022
Q4 		$22.6K Sell
76
-194
-72% -$66.3K ﹤0.01% 2419
2022
Q3 		$95K Sell
270
-200
-43% -$92.7K ﹤0.01% 2313
2022
Q2 		$206K Sell
470
-249
-35% -$138K ﹤0.01% 2267
2022
Q1 		$544K Sell
719
-371
-34% -$305K ﹤0.01% 1946
2021
Q4 		$1.36M Sell
1,090
-557
-34% -$899K ﹤0.01% 1387
2021
Q3 		$3.32M Sell
1,647
-261
-14% -$561K 0.01% 981
2021
Q2 		$4.75M Buy
1,908
+1,084
+132% +$2.66M 0.01% 883
2021
Q1 		$2.05M Buy
824
+449
+120% +$1.33M 0.01% 1256
2020
Q4 		$1.06M Sell
375
-274
-42% -$655K ﹤0.01% 1540
2020
Q3 		$1.53M Buy
+649
New +$1.6M ﹤0.01% 1298

Other funds holding MBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Advisers's MBIO Position: Q2 2023 in Review

Two Sigma Advisers sold out of Mustang Bio (MBIO) in Q2 2023, closing a stake of 72 shares — an estimated $19.9K sold.

Two Sigma Advisers first reported a position in MBIO in Q3 2020 and held it in 11 quarters. The position peaked at $4.75M in Q2 2021. 27 funds tracked by Wall St. Rank hold MBIO as of Q2 2023.

  • Two Sigma Advisers reported no remaining Mustang Bio position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 72 Mustang Bio shares in Q2 2023, an estimated $19.9K.
  • Two Sigma Advisers first reported a position in Mustang Bio in Q3 2020 and held it in 11 quarters.
  • Two Sigma Advisers's Mustang Bio position peaked at $4.75M in Q2 2021.
  • 27 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.